Stealth BioTherapeutics (the "Company" or "Stealth"), a commercial-stage biotechnology company focused on the discovery, ...
Many seniors in their 60s and 70s have likely noticed some vision loss, and this can be a normal part of aging. However, an eye condition known as age-related macular ...
At least 20 million Americans ages 40 and older have age-related macular degeneration, and the threat posed by the vision-robbing condition will only grow larger as the population ages. Despite the ...
PulseSight Therapeutics SAS, an ophthalmology clinical stage biotech company developing disruptive vectorized gene therapies with minimally-invasive delivery technology, will be presenting the results ...
PARIS, Sept. 04, 2025 (GLOBE NEWSWIRE) -- PulseSight Therapeutics, an ophthalmology biotech company developing disruptive non-viral vectorized therapies with minimally-invasive delivery technology ...
Annexon, Inc. reports complete enrollment in the ARCHER II trial for vonaprument, targeting dry AMD with topline data due 2026. Annexon, Inc. announced the successful completion of enrollment for its ...
Approaching her 91st birthday, Dame Judi Dench has offered a poignant insight into her worsening eyesight, describing the decline as "crushing". The beloved actress, who was first diagnosed with ...
The use of GLP-1 receptor agonists was associated with a substantially lower long-term risk for dry age-related macular degeneration (AMD) than the use of other weight-loss medications in adults with ...
Instant coffee consumption has been linked to age-related macular degeneration (AMD), which can cause blindness. Researchers analyzed data of patients diagnosed with AMD for their study. The team ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results